Close Menu

NEW YORK (GenomeWeb) – The New York State Department of Health has approved Counsyl's noninvasive prenatal screen, Prelude, which can be run as early as 10 weeks into gestation to determine the risk of fetal chromosomal aneuploidies that can cause Down syndrome and other conditions, the company announced today.

The South San Francisco, California-based genetic testing firm uses next-generation sequencing to analyze circulating cell-free DNA in maternal blood, as well as custom algorithms and bioinformatics tools.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.